First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies

Frauke Naumann‐Winter,Alexander Greb,Peter Borchmann,Julia Bohlius,Andreas Engert,Roland Schnell

First‐line tandem high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies

2012

Frauke Naumann‐Winter
Alexander Greb
Peter Borchmann
Julia Bohlius
Andreas Engert
Roland Schnell

Several clinical studies have compared single with tandem (also called double) autologous stem cell transplantation (ASCT) as first-line treatment in patients with symptomatic multiple myeloma (MM), one of the leading indications for ASCT worldwide.

Keywords:

Intensive care medicine
Cancer research
Immunology
Autologous stem-cell transplantation
Medicine
Multiple myeloma
Chemotherapy
Internal medicine
first line
single high dose
high dose chemotherapy
Oncology
controlled studies
in patient
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

101

References

Citations